Effectiveness and safety of dabigatran versus warfarin in “real-world” Japanese patients with atrial fibrillation: A single-center observational study
Conclusions The ability of dabigatran to prevent thromboembolism is comparable to that of warfarin; however, the major bleeding rate is lower with dabigatran in “real-world” NVAF patients.
Source: Journal of Arrhythmia - Category: Cardiology Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Bleeding | Cardiology | Clinical Trials | Coumadin | Pradaxa | Study | Thrombosis | Warfarin